Cargando…

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

BACKGROUND & AIMS: The long-term immunogenicity of anti-SARS-CoV-2 vaccines in liver transplant (LT) recipients is unknown. We aimed to assess the long-term antibody response of the Pfizer-BioNTech® BNT162b2 vaccine in LT recipients compared to controls. METHODS: LT recipients underwent anti-SAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toniutto, Pierluigi, Falleti, Edmondo, Cmet, Sara, Cussigh, Annarosa, Veneto, Laura, Bitetto, Davide, Fornasiere, Ezio, Fumolo, Elisa, Fabris, Carlo, Sartor, Assunta, Peressutti, Roberto, Curcio, Francesco, Regattin, Laura, Grillone, Lucrezia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908852/ https://www.ncbi.nlm.nih.gov/pubmed/35283215 http://dx.doi.org/10.1016/j.jhep.2022.02.015

Ejemplares similares

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2023)

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience
por: Toniutto, Pierluigi, et al.
Publicado: (2023)

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C
por: Falleti, Edmondo, et al.
Publicado: (2013)

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
por: Toniutto, Pierluigi, et al.
Publicado: (2008)

A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation
por: Mio, Catia, et al.
Publicado: (2020)

PB2525: A FOUR YEARS’ EXPERIENCE OF UNIVERSAL NEWBORN SCREENING FOR HAEMOGLOBIN DISORDERS IN UDINE, FVG, NORTHERN ITALY
por: Cmet, Sara, et al.
Publicado: (2023)

Special Issue “New Therapies of Liver Diseases”
por: Toniutto, Pierluigi
Publicado: (2022)

Intervention of PKC-θ as an immunosuppressive regimen
por: Sun, Zuoming
Publicado: (2012)

Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes
por: Domenis, Rossana, et al.
Publicado: (2019)

Patient involvement in selection of immunosuppressive regimen following transplantation
por: Popoola, Joyce, et al.
Publicado: (2014)

Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens
por: Wu, Christine, et al.
Publicado: (2006)

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal Regimen
por: Teixeira Passos, Dúlio, et al.
Publicado: (2021)

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
por: Faloppi, Luca, et al.
Publicado: (2014)

Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
por: Peghin, Maddalena, et al.
Publicado: (2021)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes
por: Domenis, Rossana, et al.
Publicado: (2018)

Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease
por: Trivin, Claire, et al.
Publicado: (2017)

Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2020)

Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
por: Gouin, Anna, et al.
Publicado: (2020)

Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation
por: Singh, Urvashi, et al.
Publicado: (2022)

Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients
por: Gerussi, Alessio, et al.
Publicado: (2020)

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
por: Edwards, B. J., et al.
Publicado: (2011)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
por: Muduma, Gorden, et al.
Publicado: (2014)

The Comparison of Parameters of Oxidative Stress in Native Rat Livers Between Different Immunosuppressive Regimens
por: Wilk, Aleksandra, et al.
Publicado: (2019)

Proteomic study on the lymphocytes from pregnant Wistar rat females treated with immunosuppressive regimen
por: Wojciuk, Bartosz, et al.
Publicado: (2022)

Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
por: Caldara, Rossana, et al.
Publicado: (2023)

Comparative Safety and Efficacy of Immunosuppressive Regimens Post-kidney Transplant: A Systematic Review
por: Qayyum, Shahid, et al.
Publicado: (2023)

Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
por: Peghin, Maddalena, et al.
Publicado: (2022)

Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma
por: Wei, Qiang, et al.
Publicado: (2016)

Peer education for medical students on health promotion and clinical risk management
por: Brunelli, Laura, et al.
Publicado: (2020)

Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients
por: Bassetti, Matteo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_co5dmiqglunic09m68khvkd7ev